ams-OSRAM Bond Tender Windows Run to December 3 as Analysts Rework Price Targets
Published on 11/19/2026 at 17:11 | Editorial boerse-global.deams-OSRAM has pushed back the acceptance deadlines on two cash tender offers for outstanding notes, extending the window to December 3 after originally setting it at November 6. Settlement on both offers is currently pencilled in for December 8.
One of the buybacks covers up to EUR 597.0 million of the company's 10.500% senior notes due 2029. The debt operations are running alongside a stretch of heavy analyst revisions and a share price that has been under pressure.
Deutsche Bank Research cut its target on the stock to CHF 18 from CHF 23, keeping a "Hold" rating. The reduction landed during a bruising seven-session run in which the equity shed 18%.
Should investors sell immediately? Or is it worth buying ams-OSRAM?
JPMorgan moved a day earlier, trimming its own target to CHF 21.70 from CHF 24 while reaffirming "Overweight." Despite that lower mark, the shares were up 2.6% in pre-market trading.
Fourth-Quarter Guidance Lands Light
The trigger for the recent weakness was the quarterly report, where ams-OSRAM's outlook for Q4 2026 came in below market expectations. Management guided revenue for the closing quarter to a range of EUR 750 million to EUR 850 million, with an adjusted EBITDA margin of 16.0% at a projected variation band of ±1.5%.
For Q3 2026, the group posted revenue of EUR 829 million and an adjusted EBITDA of EUR 135 million, a margin of 16.3%. The reported EBITDA figure was shaped by the disposal gain on the sale of the non-optical sensor business, according to the company. Reuters and AWP attributed the share-price pressure at the time to profitability falling short of expectations and a weaker-than-hoped Q4 outlook.
Alongside the results, ams-OSRAM reiterated its path to a positive free cash flow in the 2027 financial year.
Ad
ams-OSRAM Stock: New Analysis - 19 November
Fresh ams-OSRAM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
